Bioethics Today
The American Journal of Bioethics stands as the premier publication in the bioethics sector, featuring original articles that address both national and international ethical issues in health care, medicine, public health, and the life sciences. Each year, twelve issues are released, which include peer-reviewed scholarly articles, open peer commentaries, editorials, book reviews, and case studies focused on ethics in clinical care and research. Our contributors hail from diverse fields and academic backgrounds, offering informed and well-researched discussions that have been referenced by judges, politicians, journalists, educators, and countless others as a primary resource on numerous topics related to health sciences. The American Journal of Bioethics stays true to the progressive vision that established bioethics by fostering serious discussions about the societal impacts of biomedicine.
Outlet metrics
Global
#1021474
United States
#287903
Health/Medicine
#2092
Articles
-
Jan 15, 2025 |
bioethicstoday.org | Bela Fishbeyn
On 29 November 2024, a majority of the UK Parliament backed the Assisted Dying Bill in a vote described by some in the media as ‘historic’. With around 54.55% of members voting in favor, the bill will now move on to further stages of scrutiny, amendments, and further votes. If the bill receives Royal Assent, the UK will become the 16th country to decriminalize assisted dying.
-
Jan 9, 2025 |
bioethicstoday.org | Bela Fishbeyn
A controversial Bill, titled Terminally Ill Adults (End of Life) Bill, was recently proposed in England. The primary aim of this Bill is to allow adults aged 18 and over who are terminally ill and have the mental capacity to request assistance from a doctor to end their lives.
-
Sep 26, 2024 |
bioethicstoday.org | Alyssa Burgart
There isn’t enough Ozempic for everyone who wants it. People with health conditions like type 2 diabetes and severe obesity should get it before people who hope to lose a few pounds. As the new ‘miracle drug’ for weight loss, Ozempic is one of the most popular new drugs in America. This has come mostly from the media, celebrities, and TikTok influencers praising it for its short-term effects, but not from experts. The FDA approved the top-selling GLP-1 agonist in 2017 to treat diabetes.
-
Jul 28, 2024 |
bioethicstoday.org | Alyssa Burgart
In 2015, an exposé in The New York Times Magazine brought national attention to Anna Stubblefield’s sexual assault trial. Stubblefield, a white Rutgers University philosophy professor specializing in critical race and disability studies, raped a non-verbal Black man with cerebral palsy named Derrick Johnson, who is legally incapable of providing sexual consent. After a complicated legal process, Stubblefield pleaded guilty to rape in 2018.
-
Jun 13, 2024 |
bioethicstoday.org | Alyssa Burgart
Author’s note on language: Many different terms are used to describe people from Latin America or with Latin American heritage. I prefer “Latine,” and I use this term throughout unless I am referring to someone else’s work or chosen term. The first time someone referred to me as her “Latina friend” (with the subtext that I was her only Latina friend), my immediate thought was, “You need more friends.” How could I possibly be her only Latine friend? Yet, underrepresentation is common in bioethics.
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Contact Forms
Contact Form
Website
http://bioethicstoday.orgTry JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →